Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
TRMT2B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
L3MBTL1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FAM171B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LOC202025 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
NIT1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CRIPT - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PIP4K2A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
AMOTL1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HIPK2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TAB1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
WHSC1L1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
WDR47 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NPHP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
BTG3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
IRGQ - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MAVS - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NDE1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TRAFD1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FAM114A1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on